High-glucose-induced nuclear factor κB activation in vascular smooth muscle cells

Cardiovascular Research

Volumn 46, Issue 1, 2000, Pages 188-197

  Hattori, Yoshiyuki ^a   Hattori, Sachiko ^a   Sato, Noriyuki ^a   Kasai, Kikuo ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Glutathione; High glucose; Nuclear factor B; Protein kinase C; Vascular smooth muscle cells

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; GLUCOSE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANNITOL; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; NONHUMAN; OSMOLARITY; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ACETYLCYSTEINE; ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; CELLS, CULTURED; DIABETIC ANGIOPATHIES; ENZYME INHIBITORS; GLUCOSE; GLUTATHIONE; INDOLES; MALE; MALEIMIDES; MANNITOL; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; PROTEIN KINASE C; RATS; RATS, WISTAR; STIMULATION, CHEMICAL; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034114680     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00425-3     Document Type: Article

References (31)

1. Stamler J., Vaccaro O., Neaton J.D., et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 16:1993;434-444.
2. Colwell J.A. Vascular thrombosis in type II diabetes mellitus. Diabetes. 42:1993;8-11.
3. The effect of intensive treatment of diabetes on the development and progress of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med. 329:1993;977-986.
4. Lenardo M.J., Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell. 58:1989;227-229.
5. Beg A.A., Baldwin A.S. Jr. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Gene Dev. 7:1993;2064-2070.
6. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. New Engl J Med. 336:1997;1066-1071.
7. Schreck R., Albermann K., Baeuerle P.A. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Rad Res Commun. 17:1992;221-237.
8. Schmidt A.M., Yan S.D., Stern D.M. The dark side of glucose. Nat Med. 1:1995;1002-1004.
9. Bierhaus A., Chevion S., Chevion M., et al. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes. 46:1997;1481-1490.
10. Schmidt A.M., Hori O., Chen J.X., et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest. 96:1995;1395-1403.
11. Morigi M., Angioletti S., Imberti B., et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-κB-dependent fashion. J Clin Invest. 101:1998;1905-1915.
12. Chamley-Campbell J., Campbell G.R., Ross R. The smooth muscle cell in culture. Physiol Rev. 59:1979;1-61.
13. Schreiber E., Matthias P., Muller M.M., Schaffner W. Rapid detection of octamer proteins with mini-extracts, prepared from a small number of cells. Nucl Acid Res. 17:1989;6419.
14. Edgington T. More cellular signals for atherogenesis? Circulation. 98:1998;1151-1152.
15. Bourcier T., Wolff S.P., Dean R.T. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem. J. 245:1987;243-250.
16. Derubertis F.R., Craven P.A. Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes. 43:1994;1-8.
17. Pieper G.M., ul-Haq Riaz. Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J Cardiovasc Pharmacol. 30:1997;528-532.
18. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1991;405-412.
19. Sharpe P.C., Liu W.H., Yue K.K., et al. Glucose-induced oxidative stress in vascular contractile cells: comparison of aortic smooth muscle cells and retinal pericytes. Diabetes. 47:1998;801-809.
20. Chari S.N., Nath N., Rathi A.B. Glutathione and its redox system in diabetic polymorphonuclear leukocytes. Am J Med Sci. 284:1984;14-15.
21. Thomas G., Skrinska V., Lucas F.V., Schumacher O.P. Platelet glutathione and thromboxane synthesis in diabetes. Diabetes. 34:1985;951-954.
22. Murakami K., Kondo T., Ohtsuka Y., et al. Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabol: Clin Exp. 38:1989;753-758.
23. Harlan J.M., Levine J.D., Callahan K.S., Schwartz B.R., Harker L.A. Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide. J Clin Invest. 73:1984;706-713.
24. Kashiwagi A., Asahina T., Ikebuchi M., et al. Abnormal glutathione metabolism and increased cytotoxicity caused by H2O2 in human umbilical vein endothelial cells cultured in high glucose medium. Diabetologia. 37:1994;264-269.
25. Magovern G.J. Jr., Bolling S.F., Casale A.S., Bulkley B.H., Gardner T.J. The mechanism of mannitol in reducing ischemic injury: hyperosmolarity or hydroxyl scavenger? Circulation. 70:1984;I91-I95.
26. Gunel E., Caglayan F., Caglayan O., et al. Treatment of intestinal reperfusion injury using antioxidative agents. J Pediatr Surg. 33:1988;1536-1539.
27. Williams B., Schrier R.W. Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes. 41:1992;1464-1472.
28. Inoguchi T., Battan R., Handler E., et al. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA. 89:1992;11059-11063.
29. Kunisaki M., Bursell S.E., Umeda F., Nawata H., King G.L. Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes. 43:1994;1372-1377.
30. Marshall S., Bacote V., Traxinger R.R. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem. 266:1991;4706-4712.
31. Kolm-Litty V., Sauer U., Nerlich A., Lehmann R., Schleicher E.D. High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest. 101:1998;160-169.